PMID- 16952279 OWN - NLM STAT- MEDLINE DCOM- 20070129 LR - 20220330 IS - 1470-8728 (Electronic) IS - 0264-6021 (Print) IS - 0264-6021 (Linking) VI - 401 IP - 1 DP - 2007 Jan 1 TI - Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. PG - 227-34 AB - The activity and levels of the metazoan HIF (hypoxia-inducible factor) are regulated by its hydroxylation, catalysed by 2OG (2-oxoglutarate)- and Fe(II)-dependent dioxygenases. An oxygen consumption assay was developed and used to study the relationship between HIF hydroxylase activity and oxygen concentration for recombinant forms of two human HIF hydroxylases, PHD2 (prolyl hydroxylase domain-containing protein 2) and FIH (factor inhibiting HIF), and compared with two other 2OG-dependent dioxygenases. Although there are caveats on the absolute values, the apparent K(m) (oxygen) values for PHD2 and FIH were within the range observed for other 2OG oxygenases. Recombinant protein substrates were found to have lower apparent K(m) (oxygen) values compared with shorter synthetic peptides of HIF. The analyses also suggest that human PHD2 is selective for fragments of the C-terminal over the N-terminal oxygen-dependent degradation domain of HIF-1alpha. The present results, albeit obtained under non-physiological conditions, imply that the apparent K(m) (oxygen) values of the HIF hydroxylases enable them to act as oxygen sensors providing their in vivo capacity is appropriately matched to a hydroxylation-sensitive signalling pathway. FAU - Ehrismann, Dominic AU - Ehrismann D AD - Chemistry Research Laboratory, Department of Chemistry and Oxford Centre for Molecular Sciences, University of Oxford, Oxford OXI 3TA, UK. FAU - Flashman, Emily AU - Flashman E FAU - Genn, David N AU - Genn DN FAU - Mathioudakis, Nicolas AU - Mathioudakis N FAU - Hewitson, Kirsty S AU - Hewitson KS FAU - Ratcliffe, Peter J AU - Ratcliffe PJ FAU - Schofield, Christopher J AU - Schofield CJ LA - eng GR - BBS/B/07683/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom GR - WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Peptide Fragments) RN - 0 (Recombinant Proteins) RN - 0 (Repressor Proteins) RN - 0 (Transcription Factors) RN - EC 1.- (Mixed Function Oxygenases) RN - EC 1.1.3.4 (Glucose Oxidase) RN - EC 1.14.11.- (HIF1AN protein, human) RN - EC 1.14.11.2 (EGLN1 protein, human) RN - EC 1.14.11.2 (Procollagen-Proline Dioxygenase) RN - EC 1.14.11.29 (Hypoxia-Inducible Factor-Proline Dioxygenases) SB - IM MH - Cloning, Molecular MH - Glucose Oxidase/metabolism MH - Hypoxia-Inducible Factor-Proline Dioxygenases MH - Kinetics MH - Mixed Function Oxygenases MH - *Oxygen Consumption MH - Peptide Fragments/chemistry/metabolism MH - Procollagen-Proline Dioxygenase/genetics/*metabolism MH - Protein Binding MH - Recombinant Proteins/metabolism MH - Repressor Proteins/genetics/metabolism MH - Substrate Specificity MH - Transcription Factors/genetics/metabolism PMC - PMC1698668 EDAT- 2006/09/06 09:00 MHDA- 2007/01/30 09:00 PMCR- 2007/07/01 CRDT- 2006/09/06 09:00 PHST- 2006/09/06 09:00 [pubmed] PHST- 2007/01/30 09:00 [medline] PHST- 2006/09/06 09:00 [entrez] PHST- 2007/07/01 00:00 [pmc-release] AID - BJ20061151 [pii] AID - bj4010227 [pii] AID - 10.1042/BJ20061151 [doi] PST - ppublish SO - Biochem J. 2007 Jan 1;401(1):227-34. doi: 10.1042/BJ20061151.